Search results
Results from the WOW.Com Content Network
The PUMA process was established to make it more profitable for pharmaceutical companies to market drugs for children. For this purpose, new data used for PUMA approved drugs are protected for 10 years, and the applications are partially exempt from fees. [1] In September 2011, the first drug was approved under this process.
Many drugs have more than one name and, therefore, the same drug may be listed more than once. Brand names and generic names are differentiated by capitalizing brand names. See also the list of the top 100 bestselling branded drugs, ranked by sales. Abbreviations are used in the list as follows: INN = International nonproprietary name
The following are settlements reached with US authorities against pharmaceutical companies to resolve allegations of "off-label" promotion of drugs. Under the Federal Food, Drug, and Cosmetic Act, it is illegal for pharmaceutical companies to promote their products for uses not approved by the Food and Drug Administration (FDA), and corporations that market drugs for off-label indications may ...
The Federal Institute for Drugs and Medical Devices (in German: Bundesinstitut für Arzneimittel und Medizinprodukte – BfArM) is the medical regulatory body in Germany. It operates under the Federal Ministry of Health (BMG). It is headquartered in Bonn, Germany. [1] Its president is Karl Broich. [2]
Novo hit new highs last week when it became only the second European company to surpass $500 billion in market value, thanks to blockbuster sales of its weight-loss-aiding drugs through 2023.
Drug and precursor laws United Nations INCB – Single Convention on Narcotic Drugs, 1961 [1] INCB – Convention on Psychotropic Substances, 1971 [2] INCB – United Nations Convention Against Illicit Traffic in Narcotic Drugs and Psychotropic Substances, 1988 [3] INCB "Green list" – List of Psychotropic Substances under International ...
The drugs, while used to treat diabetes, show promise in reducing the risk of age-related diseases and kidney disease, by reducing oxidative stress and inflammation, and improving heart health and ...
Adopted legislation - Decisions to ban new psychoactive substances European Commission; Substances and classifications table (31/10/2008) – European Legal Database on Drugs report on all substances controlled in at least one EU country as of 31 October 2008 in XLS format Archived 25 February 2021 at the Wayback Machine